[:no]
DET MEDISINSKE FAKULTET
UNIVERSITETET I BERGEN
DISPUTAS – PH.D.-GRADEN
Luka Tandaric
Kandidaten utgår fra Klinisk institutt 2
Hovedveileder: professor Line Bjørge
Medveiledere: professor Emmet McCormack, ph.d. Liv Cecilie Vestrheim Thomsen og forsker Katrin Kleinmanns
Prøveforelesning: Fredag 23. mai 2025 kl. 10.15
Sted: Auditorium, Armauer Hansens Hus, Haukelandsveien 28
Oppgitt emne: «Targeted therapies in cancer – from their introduction to future perspectives»
Dispuptas: Fredag 23. mai 2025 kl. 12.15
Sted: Auditorium, Armauer Hansens Hus, Haukelandsveien 28
Avhandlingens tittel: “Rethinking High-Grade Serous Ovarian Carcinoma: Towards Personalized Immunotherapy through Preclinical, Translational and Clinical Evaluation of Combined CD73 and PD-L1 Blockade”
- opponent: Professor Frederic Amant, Katholieke Universiteit Leuven, Belgia
- opponent: Professor Leticia Oliveira-Ferrer, Universitätsklinikum Hamburg-Eppendorf, Tyskland
- medlem av komiteen: Forsker Carina Strell, Universitetet i Bergen
Disputasen blir ledet av professor emerita Birgitta Åsjø.
Åpent for alle interesserte
FACULTY OF MEDICINE
UNIVERSITY OF BERGEN
DEFENSE – PH.D. DEGREE
Luka Tandaric
The candidate is affiliated with the Department of Clinical Science (Klinisk institutt 2)
Main supervisor: Professor Line Bjørge
Co-supervisors: Professor Emmet McCormack, Ph.D. Liv Cecilie Vestrheim Thomsen, and Researcher Katrin Kleinmanns
Trial lecture:Friday, May 23, 2025, at 10:15 AM
Location: Auditorium, Armauer Hansen’s House, Haukelandsveien 28
Assigned topic: «Targeted therapies in cancer – from their introduction to future perspectives»
Public defense:Friday, May 23, 2025, at 12:15 PM
Location: Auditorium, Armauer Hansen’s House, Haukelandsveien 28
Title of the dissertation:
«Rethinking High-Grade Serous Ovarian Carcinoma: Towards Personalized Immunotherapy through Preclinical, Translational and Clinical Evaluation of Combined CD73 and PD-L1 Blockade»
1st opponent: Professor Frederic Amant, Katholieke Universiteit Leuven, Belgium
2nd opponent: Professor Leticia Oliveira-Ferrer, University Medical Center Hamburg-Eppendorf, Germany
3rd member of the committee: Researcher Carina Strell, University of Bergen
The defense will be chaired by Professor Emerita Birgitta Åsjø.
Open to all interested parties
[:]